Indication

Eosinophilic Granulomatous Vasculitis

1 clinical trial

2 products

Clinical trial

A Randomised, Double-blind, Active-controlled 52-week Study With an Open-label Extension to Evaluate the Efficacy and Safety of Benralizumab Compared to Mepolizumab in the Treatment of Eosinophilic Granulomatosis With Polyangiitis (EGPA) in Patients Receiving Standard of Care Therapy (MANDARA Study)

Status: Active (not recruiting), Estimated PCD: 2023-08-10

Product

Product